David F. Moore

Enzyme Replacement Therapy in Fabry Disease

Raphael Schiffmann, Jeffrey B. Kopp, Howard A. Austin et al. · JAMA · 2001 · 1.3K citations

Medicine, Pharmacology, Pharmacotherapy +13

A PER-BASELINE, DELAY-SPECTRUM TECHNIQUE FOR ACCESSING THE 21 cm COSMIC REIONIZATION SIGNATURE

Aaron R. Parsons, Jonathan C. Pober, James Aguirre et al. · The Astrophysical Journal · 2012 · 329 citations · Full text

Natural Sciences, Astronomy, Physics +14

PAPER-64 CONSTRAINTS ON REIONIZATION: THE 21 cm POWER SPECTRUM AT<i>z</i>= 8.4

Zaki S. Ali, Aaron R. Parsons, Haoxuan Zheng et al. · The Astrophysical Journal · 2015 · 265 citations · Full text

Natural Sciences, Astronomy, Physics +12

Regional Cerebral Hyperperfusion and Nitric Oxide Pathway Dysregulation in Fabry Disease

David F. Moore, Leland T.C. Scott, Mark T. Gladwin et al. · Circulation · 2001 · 256 citations · Full text

Life Sciences, Neurology, Pathobiology +16

Globotriaosylceramide induces oxidative stress and up-regulates cell adhesion molecule expression in Fabry disease endothelial cells

Jin-Song Shen, Xing‐Li Meng, David F. Moore et al. · Molecular Genetics and Metabolism · 2008 · 233 citations · Full text

Life Sciences, Biochemistry, Cell Biology +15